Birmingham Hematology Associates

Birmingham, Alabama 35223

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Early Stage Breast Cancer, HER2 + Breast Cancer, HR Positive/HER-2 Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer

Studies at this site

• Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies — Recruiting now